-

Piper Sandler Companies Elects Brian R. Sterling to Board of Directors

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brian R. Sterling to its board of directors.

After 18 years with Sandler O’Neill & Partners, L.P., Sterling joined Piper Sandler & Co. in 2020 in connection with the firms’ merger. While at Sandler O’Neill, Sterling was a principal and co-head of investment banking. Earlier in his career, he was a managing director at Merrill Lynch and worked in the corporate finance department at Wertheim Schroder & Co. Sterling began his career as an attorney with Skadden, Arps, Slate, Meagher & Flom.

Sterling retired from Piper Sandler & Co. on December 31, 2020, but will continue to provide consulting services through 2021.

“We are excited to have Brian join our board of directors. He has been a great partner and trusted advisor to us throughout the past year and he played a critical role in the successful merger between Piper and Sandler. As co-head of Sandler’s investment banking group, Brian helped grow that business into the industry leader for financial services. I know Brian will bring a valuable perspective to our board and we will continue to lean on his expertise to help us cultivate relationships across various sectors,” said Chad Abraham, Piper Sandler Companies chairman and chief executive officer.

Sterling earned a bachelor’s degree in economics from the Wharton School of the University of Pennsylvania and a Juris Doctor from Yale Law School.

About Piper Sandler

As a leading investment bank, we enable growth and success for our clients through deep sector expertise, candid advice and a differentiated, highly productive culture. We transcend transactions to define possibilities—enabling clients to achieve their short-term goals while realizing their long-term vision. Founded in 1895, the firm is headquartered in Minneapolis with offices across the United States and in London, Aberdeen and Hong Kong. Learn more at PiperSandler.com.

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Private equity strategies and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | Twitter

©2021. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Tim Carter
Chief Financial Officer
Tel: 612 303-5607
timothy.carter@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Summary
Piper Sandler Companies Elects Brian R. Sterling to Board of Directors
Release Versions

Contacts

Tim Carter
Chief Financial Officer
Tel: 612 303-5607
timothy.carter@psc.com

More News From Piper Sandler Companies

Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. “Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue e...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “We’re delighted to welcome Jason to the healthcare i...
Back to Newsroom